טוען...
Immunotherapy using slow-cycling tumor cells prolonged overall survival of tumor-bearing mice
BACKGROUND: Despite considerable progress in the development of anticancer therapies, there is still a high mortality rate caused by cancer relapse and metastasis. Dormant or slow-cycling residual tumor cells are thought to be a source of tumor relapse and metastasis, and are therefore an obstacle t...
שמור ב:
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3568736/ https://ncbi.nlm.nih.gov/pubmed/23270473 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-10-172 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|